Concepedia

Christopher D. Hepler

CD

Statistics

Publications

3

Citations

247

H-Index

3

Active since

2004

Affiliations

Eli Lilly (United States)(Current)

Christopher D. Hepler is an author at Eli Lilly (United States) specializing in pharmacology, medicine, and marine toxicology.

Publications per year

2004–2012

3

Publications

3

T0901317 is a dual LXR/FXR agonist

Keith A. Houck, Kristen M. Borchert, Christopher D. Hepler et al. · Molecular Genetics and Metabolism · 2004 · 184 citations

, , +2

Comparison of acetylcholine receptor interactions of the marine toxins, 13-desmethylspirolide C and gymnodimine

Terry A. Hauser, Christopher D. Hepler, David C. Kombo et al. · Neuropharmacology · 2012 · 48 citations

, , +16

Structure–Activity Studies of 7-Heteroaryl-3-azabicyclo[3.3.1]non-6-enes: A Novel Class of Highly Potent Nicotinic Receptor Ligands

Scott R. Breining, Matt S. Melvin, Balwinder S. Bhatti et al. · Journal of Medicinal Chemistry · 2012 · 15 citations · Full text

, , +17

1–3 of 3